Expression of PAMR1 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

PAMR1 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 7.92

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

21.7

Number of samples

141

Samples

Sample	Description	TPM
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	98.5
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	93.0
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	78.3
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	68.2
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	58.8
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	57.9
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	57.5
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	56.1
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	51.2
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	49.5
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	48.9
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	46.9
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	45.1
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	43.6
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	43.5
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	42.5
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	38.2
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	38.1
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	36.9
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	36.4
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	35.4
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	35.0
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	34.9
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	34.5
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	34.2
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	34.0
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	33.4
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	32.5
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	32.1
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	32.0
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	31.6
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	31.2
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	29.9
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	29.6
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	29.4
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	28.5
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	28.1
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	27.8
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	27.6
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	27.2
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	27.0
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	26.7
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	26.6
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	25.6
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	25.4
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	25.3
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	24.7
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	24.0
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	23.3
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	23.3
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	22.9
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	22.7
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	22.6
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	22.2
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	22.0
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	21.8
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	21.6
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	21.4
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	21.4
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	21.4
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	20.8
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	20.5
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	20.2
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	19.8
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	18.9
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	18.8
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	18.5
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	17.9
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	17.9
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	17.6
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	17.4
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	16.9
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	16.7
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	16.2
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	16.1
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	15.7
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	15.5
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	15.0
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	15.0
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	15.0
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	14.9
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	14.6
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	14.2
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	14.2
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	14.1
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	13.6
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	13.4
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	13.3
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	12.1
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	11.9
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	11.8
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	11.7
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	11.6
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	11.5
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	11.5
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	11.4
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	11.0
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	10.4
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	10.4
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	10.3
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	10.0
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	9.7
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	9.4
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	9.4
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	9.4
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	9.4
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	9.1
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	8.8
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	8.8
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	8.0
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	7.9
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	7.9
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	7.9
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	7.9
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	7.8
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	7.8
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	7.5
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	7.4
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	7.3
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	6.9
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	6.9
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	6.8
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	6.5
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	6.5
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	6.4
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	6.4
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	6.2
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	6.2
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	6.1
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	5.7
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	5.5
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	5.3
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	5.2
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	4.9
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	4.6
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	4.0
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	3.5
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	3.1
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	2.4
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	2.1
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	1.5
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

PAMR1 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 2

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

7.7

Number of samples

Samples

Sample	Description	TPM
AK216	N, NA, stage:NA, dead, 360 days	47.9
AK091	N, NA, stage:NA, dead, 210 days	27.7
AK030	N, NA, stage:NA, dead, 120 days	26.6
AK236	N, NA, stage:NA, dead, 360 days	22.5
AK153	N, NA, stage:NA, dead, 240 days	21.8
AK005	N, NA, stage:NA, dead, 240 days	21.6
AK055	N, NA, stage:NA, dead, 240 days	21.0
AK183	N, NA, stage:NA, alive, 360 days	18.4
AK006	N, NA, stage:NA, dead, 360 days	16.9
AK015	N, NA, stage:NA, alive, 720 days	16.5
AK089	N, NA, stage:NA, dead, 330 days	15.7
AK076	N, NA, stage:NA, alive, 660 days	13.9
AK139	N, NA, stage:NA, dead, 270 days	13.3
AK071	N, NA, stage:NA, dead, 540 days	12.2
AK088	N, NA, stage:NA, dead, 360 days	9.1
AK003	N, NA, stage:NA, dead, 600 days	8.4
AK188	N, NA, stage:NA, alive, 420 days	8.3
AK134	N, NA, stage:NA, dead, 360 days	7.9
AK167	N, NA, stage:NA, dead, 180 days	6.4
AK133	N, NA, stage:NA, dead, 360 days	6.2
AK173	N, NA, stage:NA, dead, 180 days	5.9
AK149	N, NA, stage:NA, dead, 420 days	5.1
AK227	N, NA, stage:NA, alive, 300 days	4.9
AK098	N, NA, stage:NA, dead, 660 days	4.8
AK158	N, NA, stage:NA, dead, 360 days	4.8
AK072	N, NA, stage:NA, dead, 150 days	4.4
AK100	N, NA, stage:NA, alive, 960 days	4.4
AK195	N, NA, stage:NA, dead, 390 days	4.2
AK178	N, NA, stage:NA, dead, 240 days	4.0
AK051	N, NA, stage:NA, dead, 360 days	3.8
AK074	N, NA, stage:NA, alive, 300 days	3.7
AK049	N, NA, stage:NA, dead, 180 days	3.7
AK165	N, NA, stage:NA, alive, 360 days	3.5
AK117	N, NA, stage:NA, dead, 210 days	3.3
AK053	N, NA, stage:NA, dead, 300 days	3.2
AK231	N, NA, stage:NA, dead, 240 days	3.1
AK226	N, NA, stage:NA, dead, 360 days	3.0
AK079	N, NA, stage:NA, dead, 210 days	3.0
AK218	N, NA, stage:NA, dead, 180 days	2.9
AK099	N, NA, stage:NA, dead, 420 days	2.9
AK142	N, NA, stage:NA, alive, 90 days	2.5
AK199	N, NA, stage:NA, alive, 1860 days	2.5
AK035	N, NA, stage:NA, dead, 210 days	2.4
AK102	N, NA, stage:NA, alive, 1740 days	2.3
AK123	N, NA, stage:NA, dead, 180 days	2.2
AK205	N, NA, stage:NA, dead, 120 days	2.1
AK185	N, NA, stage:NA, alive, 330 days	1.9
AK081	N, NA, stage:NA, dead, 180 days	1.8
AK124	N, NA, stage:NA, alive, 1920 days	1.7
AK103	N, NA, stage:NA, alive, 1320 days	1.4
AK085	N, NA, stage:NA, alive, 660 days	1.2
AK068	N, NA, stage:NA, alive, 360 days	1.1
AK213	N, NA, stage:NA, alive, 2010 days	1.1
AK043	N, NA, stage:NA, alive, 660 days	1.0
AK041	N, NA, stage:NA, alive, 810 days	0.9
AK002	N, NA, stage:NA, dead, 570 days	0.8
AK156	N, NA, stage:NA, dead, 330 days	0.8
AK066	N, NA, stage:NA, alive, 960 days	0.7
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0127480003	Tumor	1.7
CPT0190360004	Tumor	1.3
CPT0217000004	Tumor	1.1
CPT0093550003	Tumor	1.0
CPT0218330004	Tumor	1.0
CPT0168380003	Tumor	1.0
CPT0093450003	Tumor	1.0
CPT0087950003	Tumor	0.9
CPT0167970003	Tumor	0.9
CPT0087730003	Tumor	0.8
CPT0219080004	Tumor	0.7
CPT0093510003	Tumor	0.7
CPT0123530003	Tumor	0.6
CPT0218770003	Tumor	0.6
CPT0087570003	Tumor	0.6
CPT0167640003	Tumor	0.6
CPT0224540004	Tumor	0.5
CPT0189750004	Tumor	0.5
CPT0189650004	Tumor	0.5
CPT0196850003	Tumor	0.5
CPT0206450003	Tumor	0.4
CPT0162020003	Tumor	0.4
CPT0206110003	Tumor	0.4
CPT0225730003	Tumor	0.3
CPT0205570003	Tumor	0.3
CPT0168270003	Tumor	0.3
CPT0205780003	Tumor	0.3
CPT0104220003	Tumor	0.3
CPT0125570003	Tumor	0.3
CPT0162100003	Tumor	0.3
CPT0217430008	Tumor	0.2
CPT0218960004	Tumor	0.2
CPT0206780003	Tumor	0.2
CPT0206670004	Tumor	0.2
CPT0206560003	Tumor	0.2
CPT0228220003	Tumor	0.2
CPT0168080003	Tumor	0.2
CPT0189250003	Tumor	0.2
CPT0168720003	Tumor	0.1
CPT0217190003	Tumor	0.1
CPT0206230003	Tumor	0.1
CPT0167530003	Tumor	0.1
CPT0216920008	Tumor	0.1
CPT0127420003	Tumor	0.1
CPT0224330003	Tumor	0.1
CPT0182500003	Tumor	0.1
CPT0218690004	Tumor	0.1
CPT0168590003	Tumor	0.1
CPT0093360003	Tumor	0.1
CPT0089150003	Tumor	0.1
CPT0218830004	Tumor	0.1
CPT0221180003	Tumor	0.1
CPT0209440003	Tumor	0.1
CPT0064890003	Tumor	0.1
CPT0204390003	Normal	0.0
CPT0205670004	Tumor	0.0
CPT0206880003	Tumor	0.0
CPT0205890003	Tumor	0.0
CPT0204350003	Normal	0.0
CPT0189460003	Tumor	0.0
CPT0168830003	Tumor	0.0
CPT0225760003	Tumor	0.0
CPT0186100003	Tumor	-0.1
CPT0199770003	Tumor	-0.1
CPT0206000004	Tumor	-0.1
CPT0175060003	Tumor	-0.1
CPT0190240004	Tumor	-0.1
CPT0224600003	Tumor	-0.1
CPT0168480003	Tumor	-0.1
CPT0205450004	Tumor	-0.1
CPT0204420003	Normal	-0.1
CPT0064650003	Tumor	-0.1
CPT0201710003	Tumor	-0.2
CPT0125220003	Tumor	-0.2
CPT0167860004	Tumor	-0.2
CPT0167750004	Tumor	-0.2
CPT0217880003	Tumor	-0.2
CPT0217060003	Tumor	-0.2
CPT0218670003	Tumor	-0.2
CPT0079790003	Tumor	-0.2
CPT0224390004	Tumor	-0.2
CPT0162140003	Tumor	-0.3
CPT0092440003	Tumor	-0.3
CPT0218890004	Tumor	-0.3
CPT0204410003	Normal	-0.3
CPT0217100003	Tumor	-0.3
CPT0204360003	Normal	-0.3
CPT0207090003	Tumor	-0.3
CPT0104330003	Tumor	-0.3
CPT0204340003	Normal	-0.4
CPT0171580008	Tumor	-0.4
CPT0189850004	Tumor	-0.4
CPT0161730003	Tumor	-0.4
CPT0206330003	Tumor	-0.4
CPT0078580003	Tumor	-0.4
CPT0087680003	Tumor	-0.4
CPT0182580003	Tumor	-0.4
CPT0093590003	Tumor	-0.4
CPT0002410011	Tumor	-0.5
CPT0204370003	Normal	-0.5
CPT0207030003	Tumor	-0.6
CPT0204380003	Normal	-0.6
CPT0204330003	Normal	-0.7
CPT0208980003	Tumor	-0.7
CPT0125510003	Tumor	-0.7
CPT0071100003	Tumor	-0.8
CPT0204400003	Normal	-0.9
CPT0217710008	Tumor	-1.0
CPT0189570004	Tumor	-1.0
CPT0182550003	Tumor	-1.1
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis